# Eric B. Haura

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eric-b-haura/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,585 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 80 |
| i10-index | 222 |
| Last Known Institution | Moffitt Cancer Center |
| OpenAlex ID | https://openalex.org/A5064494204 |
| ORCID iD | 0000-0003-3114-1909 |
| Works | 997 |

## Researcher papers

Showing 12 of 16.

- [Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs](https://scholariq.org/papers/using-multiplexed-assays-of-oncogenic-drivers-in-lung-cancers-to-select-targeted/)
- [Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability](https://scholariq.org/papers/multiple-ras-dependent-phosphorylation-pathways-regulate-myc-protein-stability/)
- [Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis](https://scholariq.org/papers/constitutive-stat3-activity-up-regulates-vegf-expression-and-tumor-angiogenesis/)
- [Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes](https://scholariq.org/papers/large-scale-association-analysis-identifies-new-lung-cancer-susceptibility-loci/)
- [Src kinases as therapeutic targets for cancer](https://scholariq.org/papers/src-kinases-as-therapeutic-targets-for-cancer/)
- [Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study](https://scholariq.org/papers/obesity-metabolic-factors-and-risk-of-different-histological-types-of-lung/)
- [Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study](https://scholariq.org/papers/amivantamab-in-egfr-exon-20-insertion-mutated-non-small-cell-lung-cancer/)
- [Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer](https://scholariq.org/papers/mutations-in-the-i-ddr2-i-kinase-gene-identify-a-novel-therapeutic-target-in/)
- [DNA Synthesis and Repair Genes <i>RRM1</i> and <i>ERCC1</i> in Lung Cancer](https://scholariq.org/papers/dna-synthesis-and-repair-genes-i-rrm1-i-and-i-ercc1-i-in-lung-cancer/)
- [Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma](https://scholariq.org/papers/differential-association-of-stk11-and-tp53-with-kras-mutation-associated-gene/)
- [Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial](https://scholariq.org/papers/tumor-infiltrating-lymphocyte-treatment-for-anti-pd-1-resistant-metastatic-lung/)
- [HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma](https://scholariq.org/papers/hdac-inhibitors-enhance-t-cell-chemokine-expression-and-augment-response-to-pd-1/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

## Researcher university

- [Moffitt Cancer Center](https://scholariq.org/institutions/moffitt-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.